IMMU-110

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2008
01220042008

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
With the aim of improving the therapeutic utility of doxorubicin, numerous conjugates or prodrugshave been prepared to be… (More)
Is this relevant?
2008
2008
Researchers at the Weizmann Institute of Science have described an antiapoptotic signaling pathway in murine B cells that is… (More)
  • figure 1
  • table 1
Is this relevant?
2006
2006
7598 Background: The internalizing LL1 anti-CD74 antibody is an optimal agent for delivering drugs, toxins, or radionuclides to… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE IMMU-110 is a drug immunoconjugate composed of doxorubicin conjugated to the humanized anti-CD74 monoclonal antibody… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2004
2004
6535 Background: CD74, a cell-surface-expressed epitope of the HLA class II-associated invariant chain [Ii], is a unique target… (More)
Is this relevant?